Quantitative structure-activity relationships for a series of selective estrogen receptor-beta modulators

被引:8
|
作者
Salum, L. B. [1 ]
Polikarpov, I. [1 ]
Andricopulo, A. D. [1 ]
机构
[1] Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Biotecn Mol Estrutural, Lab Quim Med & Computac, BR-13560970 Sao Carlos, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
estrogen receptor; hormone replacement therapy; ER beta binding affinity; HQSAR;
D O I
10.1080/10629360701698811
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The estrogen receptor-beta subtype (ERP) is an attractive drug target for the development of novel therapeutic agents for hormone replacement therapy. Hologram quantitative structure-activity relationships (HQSAR) were conducted on a series of 6-phenylnaphthalene and 2-phenylquinoline derivatives, employing values of ER binding affinity. A training set of 65 compounds served to derive the models. The best statistical HQSAR model (q(2) =0.73 and r(2) = 0.9 1) was generated using atoms, bonds, connections and donor and acceptor as fragment distinction parameters, and fragment size default (4-7) with hologram length of 199. The model was used to predict the binding affinity of an external test set of 16 compounds, and the predicted values were in good agreement with the experimental results. The Final HQSAR model and the information obtained from 2D contribution maps should be useful for the design of novel ERP modulators having improved affinity.
引用
收藏
页码:711 / 727
页数:17
相关论文
共 50 条
  • [22] Quantitative structure-activity relationships for polychlorinated hydroxybiphenyl estrogen receptor binding affinity: An assessment of conformer flexibility
    Bradbury, SP
    Mekenyan, OG
    Ankley, GT
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 1996, 15 (11) : 1945 - 1954
  • [23] Synthesis and structure-activity relationships of a series of sigma receptor ligands
    Nahas, Roger
    Lever, John R.
    Lever, Susan Z.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 734 - 734
  • [24] Discovery and Structure-Activity Relationships of Novel ssDAF-12 Receptor Modulators
    Ceccarelli, Giada
    Goracci, Laura
    Carotti, Andrea
    Paccoia, Federico
    Passeri, Daniela
    Cipolloni, Marco
    Di Bona, Stefano
    Cruciani, Gabriele
    Pellicciari, Roberto
    Gioiello, Antimo
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (05) : 4150 - 4169
  • [25] Design and synthesis of selective estrogen modulators and estrogen receptor beta selective ligands.
    Collini, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U220 - U221
  • [26] Selective estrogen receptor-beta agonists are potent antiinflammatory agents.
    Malamas, MS
    Harris, HA
    Keith, JC
    McDevitt, B
    Gunawan, I
    Miller, CP
    Alberta, LM
    Leathurby, Y
    Manas, ES
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U38 - U39
  • [27] Quantitative structure-activity/ecotoxicity relationships (QSAR/QEcoSAR) of a series of phosphonates
    Petrescu, Alina-Maria
    Putz, Mihai V.
    Ilia, Gheorghe
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2015, 40 (03) : 800 - 824
  • [28] Quantitative structure-activity relationships for a series of symmetrical bisquaternary anticancer compounds
    Campos, JM
    Núñez, MC
    Sánchez, RM
    Gómez-Vidal, JA
    Rodríguez-González, A
    Báñez, M
    Gallo, MA
    Lacal, JC
    Espinosa, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (07) : 2215 - 2231
  • [29] Selective estrogen receptor modulators with conformationally restricted side chains.: Synthesis and structure-activity relationship of ERα-selective tetrahydroisoquinoline ligands
    Renaud, J
    Bischoff, SF
    Buhl, T
    Floersheim, P
    Fournier, B
    Geiser, M
    Halleux, C
    Kallen, J
    Keller, H
    Ramage, P
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) : 364 - 379
  • [30] Structure-activity relationships in the acronycine series
    Michel, S
    Seguin, E
    Tillequin, F
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (18) : 1689 - 1700